Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Goserelin monotherapy Variant #04 | — | R 10 511 | 84d | — | — | — | — | — |
Bicalutamide and Goserelin Variant #01 | — | R 8 166 | 84d | — | — | — | — | 1 |
Triptorelin and RT Variant #01 | — | R 2 920 | 84d | — | — | — | — | — |
Observation Partial | — | — | — | — | — | — | — | 2 |
Placebo Partial | — | — | — | — | ~21.7 mo | — | — | 10 |
Radiation therapy N/A - radiation Partial | — | — | 49d | — | — | — | — | 3 |
6 of 6 regimens shown